Morgan Stanley’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-682,578
| Closed | -$6.14M | – | 6992 |
|
|
2018
Q2 | $6.14M | Buy |
682,578
+470,181
| +221% | +$4.21M | ﹤0.01% | 2915 |
|
|
2018
Q1 | $1.94M | Sell |
212,397
-2,089,735
| -91% | -$19.3M | ﹤0.01% | 4033 |
|
|
2017
Q4 | $22.3M | Buy |
2,302,132
+1,300,970
| +130% | +$9.68M | 0.01% | 1576 |
|
|
2017
Q3 | $6.81M | Buy |
1,001,162
+802,385
| +404% | +$6.83M | ﹤0.01% | 2649 |
|
|
2017
Q2 | $2.32M | Sell |
198,777
-298,727
| -60% | -$2.95M | ﹤0.01% | 3674 |
|
|
2017
Q1 | $4.15M | Buy |
497,504
+239,467
| +93% | +$1.87M | ﹤0.01% | 3051 |
|
|
2016
Q4 | $2.02M | Sell |
258,037
-197,257
| -43% | -$1.62M | ﹤0.01% | 3920 |
|
|
2016
Q3 | $4.65M | Sell |
455,294
-352,340
| -44% | -$3.91M | ﹤0.01% | 2724 |
|
|
2016
Q2 | $9.12M | Buy |
807,634
+192,074
| +31% | +$2.4M | ﹤0.01% | 2059 |
|
|
2016
Q1 | $7.6M | Sell |
615,560
-573,847
| -48% | -$5.95M | ﹤0.01% | 2109 |
|
|
2015
Q4 | $14.2M | Buy |
1,189,407
+393,128
| +49% | +$5.09M | 0.01% | 1687 |
|
|
2015
Q3 | $12.5M | Buy |
796,279
+165,259
| +26% | +$3.34M | ﹤0.01% | 1749 |
|
|
2015
Q2 | $12.8M | Buy |
631,020
+297,384
| +89% | +$6.81M | ﹤0.01% | 1871 |
|
|
2015
Q1 | $7.94M | Sell |
333,636
-191,745
| -36% | -$3.89M | ﹤0.01% | 2304 |
|
|
2014
Q4 | $9.55M | Buy |
525,381
+414,643
| +374% | +$8.21M | ﹤0.01% | 2119 |
|
|
2014
Q3 | $2.15M | Sell |
110,738
-8,834
| -7% | -$192K | ﹤0.01% | 3376 |
|
|
2014
Q2 | $2.76M | Buy |
119,572
+44,062
| +58% | +$1.08M | ﹤0.01% | 3230 |
|
|
2014
Q1 | $1.77M | Buy |
75,510
+29,369
| +64% | +$607K | ﹤0.01% | 3527 |
|
|
2013
Q4 | $910K | Buy |
46,141
+14,995
| +48% | +$242K | ﹤0.01% | 4003 |
|
|
2013
Q3 | $418K | Buy |
31,146
+2,199
| +8% | +$31.6K | ﹤0.01% | 4452 |
|
|
2013
Q2 | $379K | Buy |
+28,947
| New | +$346K | ﹤0.01% | 4459 |
|
Morgan Stanley's KND Position: Q3 2018 in Review
Morgan Stanley sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 682,578 shares — an estimated $6.14M sold.
Morgan Stanley first reported a position in KND in Q2 2013 and held it in 21 quarters. The position peaked at $22.3M in Q4 2017. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- Morgan Stanley reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- Morgan Stanley sold 682,578 Kindred Healthcare shares in Q3 2018, an estimated $6.14M.
- Morgan Stanley first reported a position in Kindred Healthcare in Q2 2013 and held it in 21 quarters.
- Morgan Stanley's Kindred Healthcare position peaked at $22.3M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.